Your session is about to expire
β Back to Search
FLT PET/CT Imaging for Breast Cancer
Study Summary
This trial will use PET/CT imaging to look at how well an investigational drug, [18F]fluorothymidine (FLT), works in treating people with metastatic cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.My breast cancer has been confirmed by tests and shows Rb protein.I have breast cancer that has spread to an area other than the liver or bones.I am eligible for the UPCC06115 trial with ribociclib and paclitaxel.I am not pregnant and will take a pregnancy test if capable of becoming pregnant.
- Group 1: FLT PET/CT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are currently benefiting from this clinical trial?
"Enrollment for this medical trial has been concluded. It was initially posted in November of 2015 and the information was last edited on August 16th 2022. There are currently 2297 studies recruiting patients with neoplasms, breast related issues while 877 trials require participants that are receiving paclitaxel treatment."
Are there any vacancies for patients who want to join this investigation?
"Clinicaltrials.gov confirms that this investigation is not actively seeking volunteers, with the original posting having been made on November 1st 2015 and last updated August 16th 2022. Although this clinical trial has no current requirements for participants, there are 3174 other medical studies currently recruiting."
What maladies typically respond to treatment with paclitaxel?
"Paclitaxel is the preferred treatment for most cases of neoplasm metastasis. Additionally, this drug can be effective in treating a variety of other medical conditions including kaposi sarcoma, advanced directives, and fallopian tubes cancer."
Has paclitaxel been officially sanctioned by the FDA?
"Our team at Power gave paclitaxel a score of 1, as this is an early stage clinical trial and there is only limited data available on its efficacy and safety."
Are there any studies that have previously utilized paclitaxel?
"At present, 877 studies are utilizing paclitaxel. This includes 233 Phase 3 trials. Woolloongabba in Queensland is the primary site for these experiments with 47085 other locations also running them."
Share this study with friends
Copy Link
Messenger